Since Hologic was founded in 1985, we have been driven to safeguard the health of women throughout the world, offering breakthrough technologies that contribute to earlier detection, more accurate diagnoses and better overall patient care. Every year, we make substantial investments in research and development to deliver more advanced and innovative imaging, interventional and treatment solutions to save more lives. We are a world leader in several key areas of women's health including: breast cancer screening, diagnosis and treatment; minimally invasive gynecologic procedures; preterm birth risk assessment; and osteoporosis assessment.
In 2011, Hologic became the first – and to date – the only company to receive FDA approval for 3D mammography. Hologic 3D Mammography, a best-in-class technology, is available in all 50 states and in more than 50 countries. Since 2011, Hologic has expanded its 3D mammography platform to included low-dose 3D mammography technology and 3D-guided breast biopsy. Over five million women in the United States have already been screened with this life-changing technology.
Hologic’s focus and concentration in women's health is unmatched. This is one of the key reasons so many clinicians rely on our solutions to treat women at every stage of their lives.